LUTATHERA® Funded in Quebec

//LUTATHERA® Funded in Quebec

LUTATHERA® Funded in Quebec

As of September 30, 2020, the Québec Ministry of Health and Social Services has listed Lutathera on the Liste de Médicaments – Établissements. Lutathera will be reimbursed for GEP-NETs patients with advanced disease that is metastatic or not removable by surgery and has progressed despite standard somatostatin analogue therapy and whose ECOG (Eastern Clinical Oncology Group) score is 0 to 2. Please refer to the following link for the formulary listing: https://www.ramq.gouv.qc.ca/sites/default/files/documents/liste-med-etab-2020-09-30-fr.pdf

Please see the press release:

ENGLISH –can be viewed at http://www.newswire.ca/en/releases/archive/October2020/01/c7837.html
FRENCH –can be viewed at http://www.newswire.ca/fr/releases/archive/October2020/01/c9369.html

By | 2020-10-03T15:46:51+00:00 October 3rd, 2020|Treatment News|Comments Off on LUTATHERA® Funded in Quebec

About the Author: